These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5631716)

  • 21. [Effects of phenylalanine-lysine-vasopressin on cortisol secretion in normal subjects].
    Giordano G; Jacopino GE; Foppiani E
    Arch Maragliano Patol Clin; 1969; 25(6):495-502. PubMed ID: 5409095
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function.
    Landon J; James VH; Stoker DJ
    Lancet; 1965 Dec; 2(7423):1156-9. PubMed ID: 4158910
    [No Abstract]   [Full Text] [Related]  

  • 25. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of lysine-vasopressin on blood cortisol levels. Practical implications].
    Mornex R; Mallein R; Fitoussi R; Riviere JF; Pellet H; Dechavanne M
    Rev Fr Endocrinol Clin; 1971; 12(2):105-25. PubMed ID: 5138510
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans.
    Carpentier AC; Frisch F; Brassard P; Lavoie F; Bourbonnais A; Cyr D; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E693-701. PubMed ID: 17062840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The response of plasma sugar, free fatty acids, 11-hydroxycorticosteroids and growth hormone to insulin-induced hypoglycaemia and vasopressin in primary myxoedema.
    Vince FP; Boucher BJ; Cohen RD; Godfrey J
    J Endocrinol; 1970 Nov; 48(3):389-400. PubMed ID: 5480889
    [No Abstract]   [Full Text] [Related]  

  • 30. Separation of labelled oxytocin and vasopressin in some animals, using I-131 and gel filtration method.
    Abdel-Wahab MF; Abdel-Moneim Hussein M; Abdo MS
    Med Pharmacol Exp Int J Exp Med; 1967; 17(4):290-7. PubMed ID: 5631037
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition by L-cystine of the binding of 8-lysine vasopressin by porcine neurophysin.
    Thomas PJ
    Biochem J; 1966 Jul; 100(1):9C-10C. PubMed ID: 5965266
    [No Abstract]   [Full Text] [Related]  

  • 32. [Increased doses of the posterior pituitary extract in the treatment of syndromes of hypersecretion of antidiuretic hormone of cerebral origin].
    Bernard-Weil E; Sachs M; Mikol F; Soubrier JP; David M
    Bull Mem Soc Med Hop Paris; 1965 Apr 2-23; 116(7):715-28. PubMed ID: 5833902
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ghanges in plasmatic NEFA caused by light stimulation of the retina].
    Regazzini A; Rolli GP; Molinari E; Belloni G
    Rass Neurol Veg; 1968; 22(4):367-78. PubMed ID: 5714082
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of vasopressin on plasma lipids in the rat.
    Ito S; Tsukada M; Omoe K
    Jpn J Physiol; 1967 Dec; 17(6):667-77. PubMed ID: 5300933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in plasma nonesterified fatty acids and blood glucose in the newborn infant in therapy with aminophylline].
    Zanardo V; Benini F; Pesenti P; Ronconi M; Furlanut M
    Pediatr Med Chir; 1984; 6(2):253-5. PubMed ID: 6531248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of the tolbutamide test on plasmatic concentration of NEFA in the climacteric].
    Quinto P; Orlandi C
    Minerva Ginecol; 1968 Apr; 20(8):678-87. PubMed ID: 5738756
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary excretion of inorganic phosphates and free fatty acids levels in the rat sera after a single injection of lysine-vasopressin.
    Kolousek J
    Arch Int Physiol Biochim; 1968 Apr; 76(2):281-6. PubMed ID: 4174613
    [No Abstract]   [Full Text] [Related]  

  • 38. Alcohol, vasopressin, and intraocular pressure.
    Houle RE; Grant WM
    Invest Ophthalmol; 1967 Apr; 6(2):145-54. PubMed ID: 6022594
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin.
    Barbare JC; Poupon R; Jaillon P; Bories P; Aussanaire M; Darnis F; Michel H; Cheymol G
    Hepatology; 1984; 4(1):59-62. PubMed ID: 6141135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modifications induced in hepatic metabolism in rats: action of somatotropic hormones, total pituitary and posterior pituitary extracts on glucose-U-C14 utilization].
    Doneda G; Zanetti A; Bobbio Pallavicini E
    Arch Sci Med (Torino); 1966 Feb; 121(2):110-9. PubMed ID: 5947496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.